enGene Therapeutics Inc. ENGN
NASDAQ · United States · Commercial Services
$1.980.00 (0.00%)
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q3 2026 | 2026-09-08 | -0.47 | -0.43 | -10.2% | $0 | — | +1.6%$1.82→$1.85 |
| Q2 2026 | 2026-06-15 | -0.43 | -0.47 | +8.5% | — | — | +8.0%$1.62→$1.75 |
| Q1 2026 | 2026-03-09 | -0.44 | -0.57 | +22.8% | — | — | -20.0%$8.68→$6.94 |
| Q4 2025 | 2025-12-22 | -0.73 | -0.58 | -25.9% | — | — | +6.1%$8.69→$9.22 |
| Q3 2025 | 2025-09-11 | -0.57 | -0.51 | -11.8% | — | — | — |
| Q2 2025 | 2025-06-12 | -0.51 | -0.48 | -6.3% | — | — | — |
| Q1 2025 | 2025-03-10 | -0.48 | -0.37 | -29.7% | — | — | — |
| Q4 2024 | 2024-12-19 | -0.34 | -0.36 | +5.6% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.